Cambridge Cognition Holdings Plc announced that it has recently broadened its Board with two additional Non-Executive Directors, Nick Rogers and Stuart Gall, post period-end. The Company is already benefitting from their expertise and they are making significant contributions to support future growth. The Company has also strengthened its commercial leadership.

Alex Livingstone-Learmonth joined Cambridge Cognition as Chief Commercial Officer in February, bringing a wealth of sector experience, having worked in the clinical trial technology, services and solutions industry for over 20 years.